Does ENZALUTAMIDE Cause Small cell lung cancer? 6 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Small cell lung cancer have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.0% of all adverse event reports for ENZALUTAMIDE.
6
Reports of Small cell lung cancer with ENZALUTAMIDE
0.0%
of all ENZALUTAMIDE reports
1
Deaths
3
Hospitalizations
How Dangerous Is Small cell lung cancer From ENZALUTAMIDE?
Of the 6 reports, 1 (16.7%) resulted in death, 3 (50.0%) required hospitalization.
Is Small cell lung cancer Listed in the Official Label?
Yes, Small cell lung cancer is listed as a known adverse reaction in the official FDA drug label for ENZALUTAMIDE.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Small cell lung cancer?
CARBOPLATIN (74)
TARLATAMAB-DLLE (66)
ETOPOSIDE (65)
ATEZOLIZUMAB (62)
OSIMERTINIB (46)
METHOTREXATE (35)
AFATINIB (30)
ADALIMUMAB (29)
GEFITINIB (28)
NINTEDANIB (28)
Which ENZALUTAMIDE Alternatives Have Lower Small cell lung cancer Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE